ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Gene Vector Labs Seek Vector Producers

February 23, 1996

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

Children’s Oncology Group Study Shows Improved Care For Childhood Brain Tumors

October 31, 2008

States Spent Only 3.2% Of Settlement Money On Smoking Cessation.

November 21, 2008

$3.3 Million For Retinoid Contract Awarded

October 14, 1977

Texts Of Workshop Report Summarized

November 8, 1996